AngioDynamics, Inc.
Period Ending May 31, 2013 May 31, 2012 May 31, 2011 May 31, 2010
Total Revenue 342,026 221,787 215,750 216,035
Cost of Revenue 173,037 95,829 90,047 89,066
Gross Profit 168,989 125,958 125,703 126,969
Operating Expenses
Research and Development 26,319 20,511 21,373 19,275
Sales, General and Admin. 105,431 82,839 75,951 77,360
Non-Recurring Items 13,800 16,164 7,182 -
Other 16,345 9,406 9,234 9,463
Operating Income 7,094 (2,962) 11,963 20,871
Income From Continuing Operations
Add'l Income/Expense Items (2,466) (1,812) (766) (580)
Earnings Before Interest and Tax 4,628 (4,774) 11,197 20,291
Interest Expense 5,271 508 499 672
Earnings Before Tax (643) (5,282) 10,698 19,619
Income Tax (31) (188) 2,581 7,307
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (612) (5,094) 8,117 12,312
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (612) (5,094) 8,117 12,312
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (612) (5,094) 8,117 12,312